Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| ProPhase Labs, Inc. | LTRN Lantern Pharma Inc. | 13G/A | 5.8% | Dec 31, 2023 | 2y |
| Venrock Healthcare Capital Partners III, L.P. | TSHA Taysha Gene Therapies, Inc. | 13G/A | 5.6% | Dec 31, 2023 | 2y |
| Arie Belldegrun, M.D. | ALLO Allogene Therapeutics, Inc. | 13G/A | 5.8% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | EDIT Editas Medicine, Inc. | 13G/A | 6.7% | Dec 31, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | ACRS Aclaris Therapeutics, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Westchester Capital Management, LLC | AILE iLearningEngines, Inc. Common Stock | 13G | 9.69% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | MBRX Moleculin Biotech, Inc. | 13G | 9.99% | Dec 31, 2023 | 2y |
| Ionic Ventures, LLC | GROM Grom Social Enterprises Inc. Common Stock | 13G/A | 7.8% | Dec 31, 2023 | 2y |
| Cormorant Asset Management, LP | ALPN Alpine Immune Sciences, Inc. Common Stock | 13G/A | 4.39% | Dec 31, 2023 | 2y |
| Venrock Healthcare Capital Partners II, L.P. | INZY Inozyme Pharma, Inc. Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| Nikolaos Vlahos | HNST Honest Company, Inc. | 13G | 5.4% | Dec 31, 2023 | 2y |
| Portolan Capital Management, LLC | PRCH Porch Group, Inc. | 13G/A | 3.24% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | ACIW Aci Worldwide, Inc. | 13G/A | 4.3% | Dec 31, 2023 | 2y |
| K2 HealthVentures Equity Trust LLC | ELEV Elevation Oncology, Inc. Common stock | 13G/A | 4% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | LLAP Terran Orbital Corporation | 13G | 8.17% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | NSSC Napco Security Technologies, Inc | 13G | 5.7% | Dec 31, 2023 | 2y |
| TENOR CAPITAL MANAGEMENT Co., L.P. | LFLY Leafly Holdings, Inc. Common Stock | 13G/A | 0.7% | Dec 31, 2023 | 2y |
| GENERATION INVESTMENT MANAGEMENT LLP | TYGO Tigo Energy, Inc. | 13G/A | 13.09% | Dec 31, 2023 | 2y |
| Fourthstone LLC | BCAL California BanCorp \ CA | 13G/A | 8.13% | Dec 31, 2023 | 2y |
| FIR TREE CAPITAL MANAGEMENT LP | IRRX Integrated Rail and Resources Acquisition Corp. | 13G | 6.11% | Dec 31, 2023 | 2y |
| Blue Owl Capital Holdings LP | CGEM Cullinan Therapeutics, Inc. | 13G | 7.99% | Dec 31, 2023 | 2y |
| Select Equity Group, L.P. | TTC Toro Co | 13G/A | 5.4% | Dec 31, 2023 | 2y |
| TANG CAPITAL MANAGEMENT, LLC | BLPH Bellerophon Therapeutics, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| METEORA CAPITAL, LLC | PHYT Pyrophyte Acquisition Corp. | 13G | 5.04% | Dec 31, 2023 | 2y |
| Conversant Capital LLC | YELL Yellow Corporation Common Stock | 13G/A | 5% | Dec 31, 2023 | 2y |
| TIGER GLOBAL MANAGEMENT LLC | ZKH ZKH Group Ltd | 13G | 6.5% | Dec 31, 2023 | 2y |
| 272 Capital LP | PAAI Paradium.AI, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Paul L Berns | NMRA Neumora Therapeutics, Inc. | 13G | 5.2% | Dec 31, 2023 | 2y |
| M3 Funds, LLC | NECB NorthEast Community Bancorp, Inc. | 13G/A | 2.98% | Dec 31, 2023 | 2y |
| Radcliffe Capital Management, L.P. | WQGA World Quantum Growth Acquisition Corp. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | TERN Terns Pharmaceuticals, Inc. | 13G/A | 9.87% | Dec 31, 2023 | 2y |
| Sourcerock Group LLC | TALO Talos Energy Inc. | 13G | 6% | Dec 31, 2023 | 2y |
| Sonali Paul | GMED Globus Medical Inc | 13G/A | 16.24% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | FRPT Freshpet, Inc. | 13G/A | 1.67% | Dec 31, 2023 | 2y |
| Walleye Capital LLC | BBLG Bone Biologics Corp | 13G/A | 0% | Dec 31, 2023 | 2y |
| Point72 Asset Management, L.P. | PAGS PagSeguro Digital Ltd. | 13G/A | 5.6% | Dec 31, 2023 | 2y |
| PERCEPTIVE ADVISORS LLC | AMLX Amylyx Pharmaceuticals, Inc. | 13G/A | 2.8% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | BAYA Bayview Acquisition Corp | 13G | 7.65% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | CHEA Chenghe Acquisition Co. Class A Ordinary Share | 13G | 9.86% | Dec 31, 2023 | 2y |
| Cormorant Asset Management, LP | CABA Cabaletta Bio, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Venrock Healthcare Capital Partners II, L.P. | SVRA Savara Inc | 13G/A | 2.6% | Dec 31, 2023 | 2y |
| TIGER GLOBAL MANAGEMENT LLC | OKLO Oklo Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | VBNK VersaBank | 13G | 6.2% | Dec 31, 2023 | 2y |
| Edward Jay Kreps | CFLT Confluent, Inc. Class A Common Stock | 13G/A | 8.2% | Dec 31, 2023 | 2y |
| AMERIPRISE FINANCIAL INC | ALT Altimmune, Inc. | 13G | 7.79% | Dec 31, 2023 | 2y |
| 683 Capital Management, LLC | INSE Inspired Entertainment, Inc. | 13G/A | 6.9% | Dec 31, 2023 | 2y |
| 683 Capital Management, LLC | ARYE ARYA Sciences Acquisition Corp V Class A Ordinary Shares | 13G/A | 0% | Dec 31, 2023 | 2y |
| Ancient Art, L.P. | SEMR SEMrush Holdings, Inc. | 13G/A | 2.3% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | AUTL Autolus Therapeutics plc | 13G/A | 2.21% | Dec 31, 2023 | 2y |
| Walleye Capital LLC | KCGI Kensington Capital Acquisition Corp. V | 13G | 6.52% | Dec 31, 2023 | 2y |